Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
HEALTHCARE
(NY:
XLV
)
154.74
+0.92 (+0.60%)
Official Closing Price
Updated: 8:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about HEALTHCARE
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
42
43
Next >
Stocks And Sectors With The Biggest Declines
↗
September 27, 2022
The average stock in the Russell 3,000 was down 41.7% from its 52-week high as of the close yesterday. That means the average stock would need to rally 71.5% from here to get back to its high.
Via
Talk Markets
Can Healthcare Stocks Continue To Outperform?
↗
September 26, 2022
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis.
Via
Talk Markets
Are You Allowed To Speculate In A Dividend Portfolio?
↗
September 21, 2022
After over a decade of double-digit returns, many companies saw their stock price drop this year. Added to inflation and interest uncertainties, it seems complicated to find safe buying opportunities.
Via
Talk Markets
Equity Market Chart Book
↗
September 21, 2022
With tightening monetary policy, an ongoing global growth slowdown, and relatively elevated valuations, the path of least resistance continues to be lower for the equity market.
Via
Talk Markets
US Stocks Technical Analysis - Wednesday, Sept. 21
↗
September 21, 2022
Share market trading strategies: continue on the short side of the market.
Via
Talk Markets
Declining Liquidity Is Bad News For Profits And Stocks
↗
June 29, 2022
The latest data show the Fed keeps draining liquidity quite aggressively.
Via
Talk Markets
What’s Next For Biotech And Healthcare
↗
June 13, 2022
Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform.
Via
Talk Markets
Green Danger Ahead?
↗
September 19, 2022
With the Inflation Reduction Act and the European Climate Law, the West is pushing to exit oil and natural gas to prevent severe climate change and reduce dependence on foreign suppliers.
Via
Talk Markets
Stocks, Commodities, Bonds, And Fed Tapering
↗
September 18, 2022
The Fed is heralding major increases in interest rates. Little has been reported, however, about the growth of money and its impact on the economy and the markets.
Via
Talk Markets
Dollar Weakness Propels Stocks Higher; What's Next? Survey Says...
↗
September 12, 2022
The dollar can create wind in the sales of equities when there isn't much else to drive it. With Inflation data on Board for tomorrow, today's move had more to do with dollar weakness than market...
Via
Talk Markets
Sector Views: Free Cash Is King
↗
September 08, 2022
Cash flow and debt sustainability are likely to become increasingly important as real economic growth slows and credit access tightens.
Via
Talk Markets
Market X-Ray – The Big Bounce Fades
↗
August 31, 2022
Commodities were the best performing asset class earlier in the year but they are undergoing a sharp correction now.
Via
Talk Markets
Target, Corteva Among CNBC Fast Money Mentions, And This Stock Popping 2.2% After Being Named
↗
August 23, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Via
Benzinga
Oil Plunges, Sending Energy Stocks Sharply Lower: Here's What Driving The Selloff
↗
August 15, 2022
Oil is tumbling, with Brent sliding as much as $7 from Friday highs to a low of $93 while WTI puked by as much as $5, briefly dropping below $87 to the lowest level since January.
Via
Talk Markets
Home Depot Gets CNBC 'Fast Money' Call Of The Day, With Investors Picking These Final Trades
↗
August 15, 2022
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors.
Via
Benzinga
Are Medtronic And Intuitive Surgical Poised For Big Growth?
August 09, 2022
Health care is one of the better-performing sectors in 2022, with medical gear makers Medtronic and Intuitive Surgical outpacing the broader industry recently.
Via
MarketBeat
Topics
ETFs
Technology Vs. Healthcare: These Stocks Are Leading Earnings Season
↗
August 07, 2022
The current earnings season has seen some of the largest companies report quarterly financial results. The earnings reports from companies can help identify which companies are fairing well during the...
Via
Benzinga
3 Pharma Stocks' Post-Earnings Price Moves
August 04, 2022
The health care sector is participating in the S&P's nascent rally, but pharmaceuticals AbbVie, Merck and Pfizer are holding up well relative to the market.
Via
MarketBeat
Topics
ETFs
Stocks
U.S. Weekly FundFlows Insight Report: Despite a Market Rally, Conventional Fund and ETF Investors Continue to Shun Equity Funds During the Fund-Flows Week
↗
July 21, 2022
Investors were overall net redeemers of fund assets (including those of conventional funds and ETFs) for the first week in three, withdrawing a net $7.2 billion for the fund-flows week ended Wednesday,...
Via
Talk Markets
Broad Market Rallies Despite Currency Headwinds
↗
July 20, 2022
HealthCare and Biotech shares have been strong over the past 30 days as investors have sought trades away from macro and earnings concerns. In times of volatility portfolio strategists may re-balance...
Via
Talk Markets
Investors Remain Bearish, Maybe A Positive For Equities
↗
July 11, 2022
Both individual and institutional investors have been expressing a low level of bullishness, levels generally associated with equity market bottoms.
Via
Talk Markets
Nasdaq: Breakout Or Breakdown?
↗
July 07, 2022
There is both a bullish wedge and bear flag developing on the QQQ chart. Which pattern should you be watching?
Via
Talk Markets
A Look at 22Q2 Earnings Dispersion ahead of Earnings Season
↗
July 05, 2022
Earnings expectations have remained high across U.S., Europe, and Canada as we enter the second half of the year with most global benchmarks down 15-20%.
Via
Talk Markets
Something Still Smells. Actions You Should Take Now!
↗
July 03, 2022
In June alone, the S&P 500, the Dow, the Nasdaq 100, and the Small-Cap indices were all down over 8% for the month. It wasn't pretty. Fortunately, it's halftime, and this can create an opportunity for...
Via
Talk Markets
CNBC's Final Trades: Buy Coca-Cola And Health Care, Short These Two
↗
June 30, 2022
On CNBC’s “Halftime Report Final Trades,” Liz Young of BNY Mellon Investment Management chose Health Care Select Sector SPDR Fund (NYSE: XLV).
Via
Benzinga
Stock Market Review - Thursday, June 23
↗
June 23, 2022
A monthly review of the stock market.
Via
Talk Markets
CNBC's Final Trades: Walt Disney, Amazon, Microsoft And 2 Ways To Gain Health Care Exposure
↗
June 23, 2022
On CNBC’s “Halftime Report Final Trades,” Michael Farr from Farr, Miller & Washington said he was adding to Walt Disney Co (NYSE: DIS).
Via
Benzinga
Bear Market Rally Lifts HealthCare Stocks Off Bottom
↗
June 22, 2022
Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma.
Via
Talk Markets
Leading And Lagging Sectors For June 15, 2022
↗
June 15, 2022
Gainers Symbol Name Price Change ($) Change (%) Volume
Via
Benzinga
Leading And Lagging Sectors For June 14, 2022
↗
June 14, 2022
Gainers Symbol Name Price Change ($) Change (%) Volume
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
42
43
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.